Medbase, part of the group of Migros, and the owners of zahnarztzenturm.ch signed an agreement to acquire the majority of the shares
Tags :Walder Wyss
BioMarin Pharmaceutical announced that the company has entered into a preclinical collaboration and license agreement with DiNAQOR, a gene therapy platform company,
Walder Wyss advised SkyCell in this transaction. The team was led by partner Alex Nikitine and included senior associate Dominik Aerni
Walder Wyss startup desk has been appointed as official legal partner of the Health Innovation Hub of the University Hospital Zurich (USZ)
Walder Wyss acted as advisor to the acquirer in all legal aspects of the transaction. The team is led by partner Stefan Knobloch (corporate and m&a) and includes managing associate Christian Lütolf (corporate
The Swiss FinTech startup Expense Robot closed a seed investment round co-led by Swisscom Ventures and SIX Group. Walder Wyss advised Swisscom Ventures on this transaction. The team was led by partner Patrick W. Vogel
Häcki has a particular interest and legal expertise in real estate law including (commercial) tenancy and construction law. Furthermore, Kathrin Häcki's practice focuses on foundation law as well as insolvency and restucturing.
19 Swiss companies of the Media Markt group have been merged into Media Markt Management as absorbing entity. These 19 mergers were all filed for entry in the commercial register simultaneously and were entered simultaneously in the
Deal & transactions
Celanese acquired Nouryon’s redispersible polymer powders business: the advisors
Celanese Corporation, a global chemical and specialty materials company, acquired Nouryon’s redispersible polymer powders business offered under the Elotex brand.
Due to the enormous risks of Covid19, companies will have to process highly sensitive health data of employees. This situation generates lots of questions on how data protection compliance can be ensured in these exceptional
